These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38007555)

  • 1. Multi-omics analysis of hospital-acquired diarrhoeal patients reveals biomarkers of enterococcal proliferation and Clostridioides difficile infection.
    Bosnjak M; Karpe AV; Van TTH; Kotsanas D; Jenkin GA; Costello SP; Johanesen P; Moore RJ; Beale DJ; Srikhanta YN; Palombo EA; Larcombe S; Lyras D
    Nat Commun; 2023 Nov; 14(1):7737. PubMed ID: 38007555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut metabolites predict Clostridioides difficile recurrence.
    Dawkins JJ; Allegretti JR; Gibson TE; McClure E; Delaney M; Bry L; Gerber GK
    Microbiome; 2022 Jun; 10(1):87. PubMed ID: 35681218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiota-based markers predictive of development of Clostridioides difficile infection.
    Berkell M; Mysara M; Xavier BB; van Werkhoven CH; Monsieurs P; Lammens C; Ducher A; Vehreschild MJGT; Goossens H; de Gunzburg J; Bonten MJM; Malhotra-Kumar S;
    Nat Commun; 2021 Apr; 12(1):2241. PubMed ID: 33854066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
    Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
    Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients.
    Fishbein SRS; Hink T; Reske KA; Cass C; Struttmann E; Iqbal ZH; Seiler S; Kwon JH; Burnham CA; Dantas G; Dubberke ER
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33441409
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical characteristics of Clostridium difficile infection in hospitalized patients with antibiotic-associated diarrhea in a university hospital in China.
    Zhou FF; Wu S; Klena JD; Huang HH
    Eur J Clin Microbiol Infect Dis; 2014 Oct; 33(10):1773-9. PubMed ID: 24820293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton Pump Inhibitor-Induced Gut Dysbiosis Increases Mortality Rates for Patients with Clostridioides difficile Infection.
    Lin CY; Cheng HT; Kuo CJ; Lee YS; Sung CM; Keidan M; Rao K; Kao JY; Hsieh SY
    Microbiol Spectr; 2022 Aug; 10(4):e0048622. PubMed ID: 35863023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Domestic canines do not display evidence of gut microbial dysbiosis in the presence of Clostridioides (Clostridium) difficile, despite cellular susceptibility to its toxins.
    Stone NE; Nunnally AE; Jimenez V; Cope EK; Sahl JW; Sheridan K; Hornstra HM; Vinocur J; Settles EW; Headley KC; Williamson CHD; Rideout JR; Bolyen E; Caporaso JG; Terriquez J; Monroy FP; Busch JD; Keim P; Wagner DM
    Anaerobe; 2019 Aug; 58():53-72. PubMed ID: 30946985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlating Antibiotic-Induced Dysbiosis to
    Moore JH; Salahi A; Honrado C; Warburton C; Tate S; Warren CA; Swami NS
    ACS Infect Dis; 2023 Oct; 9(10):1878-1888. PubMed ID: 37756389
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Battaglioli EJ; Hale VL; Chen J; Jeraldo P; Ruiz-Mojica C; Schmidt BA; Rekdal VM; Till LM; Huq L; Smits SA; Moor WJ; Jones-Hall Y; Smyrk T; Khanna S; Pardi DS; Grover M; Patel R; Chia N; Nelson H; Sonnenburg JL; Farrugia G; Kashyap PC
    Sci Transl Med; 2018 Oct; 10(464):. PubMed ID: 30355801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil.
    Maestri AC; Raboni SM; Morales HMP; Ferrari LF; Tuon FFB; Losso A; Marconi C; Nogueira KDS
    Anaerobe; 2020 Aug; 64():102238. PubMed ID: 32717474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of Clinical Severity With Stool Microbiome Changes in Clostridioides difficile Infection.
    Castañeda-Mogollón D; Doolan CP; Toppings NB; Amarasekara R; Tran TA; Pillai DR
    Arch Pathol Lab Med; 2023 Jul; 147(7):774-785. PubMed ID: 36308712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota in burned patients with Clostridioides difficile infection.
    Shoaei P; Shojaei H; Siadat SD; Moshiri A; Vakili B; Yadegari S; Ataei B; Khorvash F
    Burns; 2022 Aug; 48(5):1120-1129. PubMed ID: 34924229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Para-cresol production by Clostridium difficile affects microbial diversity and membrane integrity of Gram-negative bacteria.
    Passmore IJ; Letertre MPM; Preston MD; Bianconi I; Harrison MA; Nasher F; Kaur H; Hong HA; Baines SD; Cutting SM; Swann JR; Wren BW; Dawson LF
    PLoS Pathog; 2018 Sep; 14(9):e1007191. PubMed ID: 30208103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Intestinal Mycobiota of Patients with Clostridioides difficile Infection among a Prospective Inpatient Cohort.
    Cao Y; Wang L; Ke S; Kelly CP; Pollock NR; Villafuerte Gálvez JA; Daugherty K; Xu H; Yao J; Chen Y; Liu YY; Chen X
    Microbiol Spectr; 2022 Aug; 10(4):e0136222. PubMed ID: 35867408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiota-accessible carbohydrates suppress Clostridium difficile infection in a murine model.
    Hryckowian AJ; Van Treuren W; Smits SA; Davis NM; Gardner JO; Bouley DM; Sonnenburg JL
    Nat Microbiol; 2018 Jun; 3(6):662-669. PubMed ID: 29686297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A High-Carbohydrate Diet Prolongs Dysbiosis and Clostridioides difficile Carriage and Increases Delayed Mortality in a Hamster Model of Infection.
    Bhute SS; Mefferd CC; Phan JR; Ahmed M; Fox-King AE; Alarcia S; Villarama JV; Abel-Santos E; Hedlund BP
    Microbiol Spectr; 2022 Aug; 10(4):e0180421. PubMed ID: 35708337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile.
    Collins DA; Riley TV
    Lett Appl Microbiol; 2022 Sep; 75(3):526-536. PubMed ID: 35119124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of hospital-onset Clostridioides difficile infection in children with antibiotic-associated diarrhea.
    Polat M; Tapısız A; Demirdağ TB; Yayla BC; Kara SS; Tezer H; Belet N; Çırak MY
    Am J Infect Control; 2023 Aug; 51(8):879-883. PubMed ID: 36535316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disordered Intestinal Microbial Communities During
    Chen Y; Lv T; Yan D; Zheng L; Zheng B; Wang J; Gu S; Li L
    Front Cell Infect Microbiol; 2022; 12():825189. PubMed ID: 35433508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.